Given that connexin hemichannels, especially those built up by Cx43, play a role in inflammation, it seems conceivable to assume that connexin hemichannels are affected by drugs formerly regarded as COVID-19 drugs [1,20,21,22]. The gene discussed is GJA1; the disease is COVID-19.